Human leukocyte antigen phenotypes and hepatitis C viral load

Journal of Clinical Virology

Volumn 32, Issue 2, 2005, Pages 144-150

  Wang, Li Yu ^a   Lin, Hans Hsienhong ^b   Lee, Tsung Dao ^b   Wu, Ya Fang ^a   Hu, Chi Tan ^b   Cheng, Mu Liang ^c   Lo, Shih Yen ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c MENNONITE CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

HBsAg; HCV; hepatitis B surface antigen; hepatitis C virus; Hepatitis C virus; HLA; human leukocyte antigen; Human leukocyte antigen; Real time RT PCR; sequence specific oligonucleotide probe hybridization; SSOPH; Viral load

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HLA SYSTEM; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HETEROZYGOTE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE PROBES; PHENOTYPE; RNA, VIRAL; VIRAL LOAD;

EID: 11844304051     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.05.011     Document Type: Article

References (29)

1. El-Serag H.B. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 36(5 Suppl.):2002;S74-S83
2. Fanning L.J., Levis J., Kenny-Walsh E., Whelton M., O'Sullivan K., Shanahan F. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology. 33:2001;224-230
3. Fukumoto T., Berg T., Ku Y., Bechstein W.O., Knoop M., Lemmens H.P., et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation evidence for rapid turnover of serum virions. Hepatology. 24(6):1996;1351-1354
4. Hashimoto M., Chayama K., Kobayashi M., Tsubota A., Arase Y., Saitoh S., et al. Fluctuations of hepatitis C virus load are not related to amino acid substitutions in hypervariable region 1 and interferon sensitivity determining region. J. Med. Virol. 58(3):1999;247-255
5. Hue S., Cacoub P., Renou C., Halfon P., Thibault V., Charlotte F., et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related diseases. J. Infect. Dis. 186(1):2002;106-109
6. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology. 36(5):2002;S21-S29
7. Houghton M. Hepatitis C virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 1035-95.
8. Isaguliants M.G., Ozeretskovskaya N.N. Host background factors contributing to hepatitis C virus clearance. Curr. Pharm. Biotechnol. 4(3):2003;185-193
9. Kao J.H., Chen P.J., Lai M.Y., Yang P.M., Sheu J.C., Wang T.H., et al. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J. Clin. Gastroenterol. 21:1995;233-237
10. Korenaga M., Hino K., Okita K. A possible role of human leukocyte antigen (HLA) typing for predicting response to interferon therapy in chronic hepatitis C. Nippon Rinsho. 59(7):2001;1345-1350
11. Krarup H.B., Moller J.M., Christensen P.B., Fuglsang T., Ingerslev J., Arnfred T., et al. Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups. J. Viral. Hepat. 7(6):2000;435-439
12. Lee T.D., Lee A., Lai S., Huang R., Yan L., Lee G. An apparent functional correlation between variations in amino acid residues in HLA-DR4.1 and 4.2 serological subtypes and oligonucleotide characterization. Eur. J. Immunogenet. 23:1996;129-140
13. Lee A., Huang R., Yan L., Shaw C.K., Zeng S., Lin P.Y., et al. Heterogeneity of HLA-DR2 haplotypes in Caucasoid Americans, African Americans, Chinese Americans. Eur. J. Immunogenet. 26:1999;275-280
14. Lo S.Y., Lin H.H. Variations within hepatitis C virus E2 protein and response to interferon treatment. Virus Res. 75(2):2001;107-112
15. Lo S.Y., Peng K.F., Ma H.C., Yu J.H., Li Y.H., Lin H.H., et al. Prevalence of TT virus DNA in eastern Taiwan aborigines. J. Med. Virol. 59:1999;198-203
16. Matthews-Greer J.M., Caldito G.C., Adley S.D., Willis R., Mire A.C., Jamison R.M., et al. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 8(4):2001;690-694
17. Penn D.J., Damjanovich K., Potts W.K. MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc. Natl. Acad. Sci. U.S.A. 99(17):2002;11260-11264
18. Sagnelli E., Coppola N., Messina V., Di Caprio D., Marrocco C., Marotta A., et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology. 36(5):2002;1285-1291
19. Seeff L.B. Natural history of chronic hepatitis C. Hepatology. 36(5 Suppl.):2002;S35-S46
20. Takeuchi T., Katsume A., Tanaka T., Abe A Inoue K., Tsukiyama-Kohara K., Kawaguchi R., et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology. 116:1999;636-642
21. Thio C.L., Gao X., Goedert J.J., Vlahov D., Nelson K.E., Hilgartner M.W., et al. HLA-Cw*04 and hepatitis C virus persistence. J. Virol. 76(10):2002;4792-4797
22. Thursz M.R., Thomas H.C., Greenwood B.M., Hill A.V. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat. Genet. 17:1997;11-12
23. Tokushige K., Tsuchiya N., Hasegawa K., Hashimoto E., Yamauchi K., Komatsu T., et al. Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV. Am. J. Gastroenterol. 98(1):2003;160-166
24. Trepo C., Vierling J., Zeytin F.N., Gerlich W.H. The first Flaviviridae symposium. Intervirology. 40:1997;279-288
25. Vejbaesya S., Songsivilai S., Tanwandee T., Rachaibun S., Chantangpol R., Dharakul T. HLA association with hepatitis C virus infection. Hum. Immunol. 61:2000;348-353
26. White P.A., Zhai X., Carter I., Zhao Y., Rawlinson W.D. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J. Clin. Microbiol. 38(2):2000;477-482
27. Whitton JL, Oldstone MBA. Immune response to viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 345-74.
28. Wu Y.F., Wang L.Y., Lee T.D., Lin H.H., Hu C.T., Cheng M.L., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J. Med. Virol. 72:2004;17-25
29. Zeuzem S. The kinetics of hepatitis C virus infection. Clin. Liver Dis. 5(4):2001;917-930